[go: up one dir, main page]

WO2018101663A3 - 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법 - Google Patents

생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법 Download PDF

Info

Publication number
WO2018101663A3
WO2018101663A3 PCT/KR2017/013168 KR2017013168W WO2018101663A3 WO 2018101663 A3 WO2018101663 A3 WO 2018101663A3 KR 2017013168 W KR2017013168 W KR 2017013168W WO 2018101663 A3 WO2018101663 A3 WO 2018101663A3
Authority
WO
WIPO (PCT)
Prior art keywords
biotissue
clearing
composition
same
clearing method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2017/013168
Other languages
English (en)
French (fr)
Other versions
WO2018101663A2 (ko
Inventor
박순현
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP17876444.5A priority Critical patent/EP3550029B1/en
Priority to CN201780073234.0A priority patent/CN109996887A/zh
Priority to US16/462,973 priority patent/US11726012B2/en
Priority to JP2019548842A priority patent/JP6945881B2/ja
Publication of WO2018101663A2 publication Critical patent/WO2018101663A2/ko
Publication of WO2018101663A3 publication Critical patent/WO2018101663A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/04—Sodium compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/4833—Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G01N2001/305—Fixative compositions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법에 관한 것이다.
PCT/KR2017/013168 2016-11-29 2017-11-20 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법 Ceased WO2018101663A2 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP17876444.5A EP3550029B1 (en) 2016-11-29 2017-11-20 Composition for biotissue clearing and biotissue clearing method using same
CN201780073234.0A CN109996887A (zh) 2016-11-29 2017-11-20 用于清除生物组织的组合物和使用其清除生物组织的方法
US16/462,973 US11726012B2 (en) 2016-11-29 2017-11-20 Composition for biotissue clearing and biotissue clearing method using same
JP2019548842A JP6945881B2 (ja) 2016-11-29 2017-11-20 生体組織透明化用組成物及びそれを用いた生体組織の透明化方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020160160031A KR101866249B1 (ko) 2016-11-29 2016-11-29 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법
KR10-2016-0160031 2016-11-29

Publications (2)

Publication Number Publication Date
WO2018101663A2 WO2018101663A2 (ko) 2018-06-07
WO2018101663A3 true WO2018101663A3 (ko) 2018-08-09

Family

ID=62241633

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/013168 Ceased WO2018101663A2 (ko) 2016-11-29 2017-11-20 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법

Country Status (6)

Country Link
US (1) US11726012B2 (ko)
EP (1) EP3550029B1 (ko)
JP (1) JP6945881B2 (ko)
KR (1) KR101866249B1 (ko)
CN (1) CN109996887A (ko)
WO (1) WO2018101663A2 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018113723A1 (en) * 2016-12-22 2018-06-28 The University Of Hong Kong Compositions and methods for clearing tissue
US10359344B2 (en) * 2017-04-21 2019-07-23 Korea Research Institute Of Chemical Technology Composition for clearing of biotissue and clarity method for biotissue using thereof
KR102141496B1 (ko) * 2018-04-27 2020-08-06 한국화학연구원 투명화된 거대조직의 면역염색용 조성물 및 이를 이용한 투명화된 거대 생체 조직의 면역염색 방법
CN110763661B (zh) * 2018-07-25 2022-03-22 中国科学院合肥物质科学研究院 处理液组合物、试剂盒和生物器官透明化同时进行免疫标记的方法
KR102277657B1 (ko) * 2019-02-01 2021-07-15 주식회사 바이나리 뇌 조직 투명화를 이용한 시냅스 기능 장애 평가 방법
KR102590850B1 (ko) * 2019-02-14 2023-10-19 주식회사 바이나리 뇌 조직 투명화를 이용하여 약물의 뇌혈관장벽 통과 여부를 모니터링 하는 방법
KR102248719B1 (ko) * 2019-07-11 2021-05-06 주식회사 바이나리 뇌 조직 투명화용 조성물 및 이를 이용한 우울증 약리 효능의 평가 방법
JP7579578B2 (ja) * 2019-09-24 2024-11-08 国立大学法人大阪大学 細胞適合性組織透明化組成物
KR102477568B1 (ko) 2020-06-16 2022-12-15 서울대학교산학협력단 1 mm 이하 크기 생체 시료의 투명화 전처리 방법 및 이를 포함하는 생체 시료의 투명화 방법
KR20250081553A (ko) * 2023-11-29 2025-06-05 주식회사 바이나리 생체조직 투명화 가속화 용액을 포함하는 생체조직 투명화용 키트, 생체조직 투명화용 전기영동 장치 및 이를 이용한 생체조직 투명화 방법
WO2025205773A1 (ja) * 2024-03-29 2025-10-02 学校法人金沢医科大学 透明化前処理

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2865685A1 (en) * 2013-10-24 2015-04-29 Westfälische Wilhelms-Universität Münster Electrophoretic analysis of a sample using N-Lauroylsarcosine
US20150285718A1 (en) * 2012-10-30 2015-10-08 Kanazawa Medical University Kit for producing cleared biological specimens and method for producing cleared biological specimens
WO2016023009A1 (en) * 2014-08-07 2016-02-11 Wake Forest University Health Sciences Compositions and methods for clearing a biological sample

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2635001C (en) * 1997-08-20 2012-12-04 Ervin Essenfeld High quality, continuous throughput, tissue fixation-dehydration-fat removal-impregnation
FR2774988B1 (fr) * 1998-02-16 2000-05-05 Commissariat Energie Atomique Procede de purification de la prpres a partir d'un echantillon biologique et ses applications
FR2801106B1 (fr) * 1999-11-12 2007-10-05 Commissariat Energie Atomique Procede de diagnostic d'une esst provoquee par une souche d'atnc dans un echantillon biologique et son utilisation dans le diagnostic differentiel des differentes souches d'atnc
JP2003066035A (ja) * 2001-08-06 2003-03-05 Anse Ko 水溶性組織清澄溶液
JP2007097508A (ja) * 2005-10-05 2007-04-19 Tohoku Univ 哺乳動物組織材料の前処理方法
FR2893952B1 (fr) * 2005-11-25 2008-02-22 Bio Rad Pasteur Sa Procede d'identification du genotype en position 171 de la proteine prion d'ovin ainsi que trousses de mise en oeuvre de ce procede.
JP5490414B2 (ja) * 2006-01-13 2014-05-14 ベンタナ・メデイカル・システムズ・インコーポレーテツド 生体サンプル処理用組成物及び方法
JP2012518171A (ja) * 2009-02-13 2012-08-09 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 組織に基づいた診断のためのシステム、方法及びデバイス
CN108061677B (zh) * 2010-03-12 2021-10-29 国立研究开发法人理化学研究所 用于生物材料的澄清试剂和其用途
EP2703801B1 (en) * 2011-04-28 2020-11-25 Riken Method for making biological material transparent
US8445284B2 (en) * 2011-06-17 2013-05-21 Constitution Medical, Inc. Fixative and staining solutions
EP4163617A1 (en) * 2012-08-09 2023-04-12 The Board of Trustees of the Leland Stanford Junior University Methods and compositions for preparing biological specimens for microscopic analysis
JP6118523B2 (ja) * 2012-08-22 2017-04-19 学校法人慶應義塾 エチレングリコール及び界面活性剤を含む溶液を用いた細胞分画法
WO2014115206A1 (ja) * 2013-01-28 2014-07-31 独立行政法人科学技術振興機構 組織透明化方法、組織透明化試薬及び組織観察方法
US9572911B2 (en) * 2013-03-15 2017-02-21 University Of Florida Research Foundation, Incorporated Method for decellularization of tissue grafts
JP2015049101A (ja) * 2013-08-30 2015-03-16 オリンパス株式会社 生体透明化剤
US9778154B2 (en) * 2013-09-20 2017-10-03 California Institute Of Technology Methods for phenotyping of intact whole tissues
KR101563826B1 (ko) * 2014-12-31 2015-10-28 계명대학교 산학협력단 조직 투명화 방법
JP6601842B2 (ja) * 2015-12-17 2019-11-06 国立大学法人名古屋大学 植物組織透明化剤
EP3430398A1 (en) * 2016-03-18 2019-01-23 Beckman Coulter Inc. Subcellular localization of target analytes
JP6818346B2 (ja) * 2016-04-28 2021-01-20 国立大学法人浜松医科大学 電子顕微鏡によるナノ粒子の直接的な同定・定量のための検出キットおよび方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150285718A1 (en) * 2012-10-30 2015-10-08 Kanazawa Medical University Kit for producing cleared biological specimens and method for producing cleared biological specimens
EP2865685A1 (en) * 2013-10-24 2015-04-29 Westfälische Wilhelms-Universität Münster Electrophoretic analysis of a sample using N-Lauroylsarcosine
WO2016023009A1 (en) * 2014-08-07 2016-02-11 Wake Forest University Health Sciences Compositions and methods for clearing a biological sample

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LEE, E. ET AL.: "ACT-PRESTO: Rapid and Consistent Tissue Clearing and Labeling Method for 3-dimensional (3D) Imaging", SCIENTIFIC REPORTS, vol. 6, 11 January 2016 (2016-01-11), pages 1 - 13, XP055537575 *
ZHU, D. ET AL.: "Recent Progress in Tissue Optical Clearing", LASER & PHOTONICS REVIEWS, vol. 7, no. 5, September 2013 (2013-09-01), pages 732 - 757, XP055217131 *

Also Published As

Publication number Publication date
KR20180060494A (ko) 2018-06-07
EP3550029A4 (en) 2020-07-29
WO2018101663A2 (ko) 2018-06-07
US20200271553A1 (en) 2020-08-27
KR101866249B1 (ko) 2018-06-12
JP6945881B2 (ja) 2021-10-06
EP3550029B1 (en) 2024-07-10
JP2020513573A (ja) 2020-05-14
EP3550029A2 (en) 2019-10-09
CN109996887A (zh) 2019-07-09
US11726012B2 (en) 2023-08-15

Similar Documents

Publication Publication Date Title
WO2018101663A3 (ko) 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법
WO2018109170A3 (en) Il-11ra antibodies
WO2017031360A8 (en) Capture of nucleic acids using a nucleic acid-guided nuclease-based system
WO2018109174A3 (en) Il-11 antibodies
LT3577110T (lt) 8-oksetan-3-il-3,8-diazabiciklo[3.2.1]oktan-3-ilo pakeistieji junginiai, kaip živ inhibitoriai
WO2017099494A8 (ko) Cpf1을 포함하는 유전체 교정용 조성물 및 그 용도
EP4410805A3 (en) Raav-based compositions and methods for treating amyotrophic lateral sclerosis
SG11202103781TA (en) Products, uses & methods
SG10201803042PA (en) Anti-tim-3 antibodies
WO2015168019A3 (en) Anti-ptk7 antibody-drug conjugates
WO2016044463A3 (en) Mk2 inhibitors and uses thereof
IL284800A (en) Methods, uses and compositions
WO2018071910A3 (en) Anti-il1-rap antibodies
GB2577981B (en) Methods, products & Uses relating thereto
WO2016033437A3 (en) Polyethers, polyamines, polythioethers, and methods for making same
GB202017595D0 (en) Compositions, and methods and uses relating thereto
WO2017087912A3 (en) Ratiometric biosensors and non-geometrically modulated fret
WO2016166296A3 (en) Humanized anti-axl antibodies
GB201813648D0 (en) Methods, products & uses relating thereto
IL285204A (en) Formulation of apavicin, method for its preparation
EP3398943A4 (en) Method for producing 1,2,3,5,6-pentathiepane
WO2016181204A8 (en) Method of making a mercury based compound, mercury based compound, methods of using the mercury based compound and uses of the mercury based compound
GB201912016D0 (en) Methods, products & uses relating thereto
GB201912021D0 (en) Methods, products & Uses relating thereto
WO2016047924A3 (ko) 형광 표지된 신규 디에콜 유도체

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17876444

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2019548842

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2017876444

Country of ref document: EP

Effective date: 20190701